UVM Wins $38M ARPA-H Contract to Build Real-Time AI Digital Twins for ICU Sepsis and Trauma

Good morning, HealthTech insiders. The standard physical exam tools that clinicians carry into hospital wards and outpatient clinics are acquiring specialist diagnostic intelligence at a remarkable velocity.

While the University of Vermont secured a thirty-eight million dollar federal ARPA-H contract to build real-time AI digital twins that simulate drug responses for critically ill ICU patients, Eko Health achieved FDA clearance for its next-generation CORE 300 AI stethoscope, pricing automated structural heart detection at acoustic price parity for mass-market clinician adoption. Concurrently, RIVANNA secured FDA clearance for BoneEnhance, converting portable bedside ultrasound into real-time 3D skeletal anatomical maps.

The unifying momentum across today's developments is the democratization of point-of-care diagnostics. Rather than requiring complex referral scheduling or sending patients into high-cost imaging suites, healthcare technology is embedding real-time computer vision, acoustic AI, and physiological simulation directly into the clinician's hands at the bedside.

In today's Signal:

• UVM wins $38M ARPA-H contract: Developing ReSCUED real-time AI digital twins to personalize ICU sepsis and trauma immunotherapy.

• Eko Health clears FDA 510(k) for CORE 300: Bringing automated structural heart triage to everyday physical exams at acoustic price parity.

• RIVANNA secures FDA clearance for BoneEnhance: Automating 3D bone and musculoskeletal segmentation on Accuro XV ultrasound.

• Follow the Money & Investor Signal: Capital concentrates in point-of-care diagnostic leverage and high-acuity computational simulation.

In partnership with

Yes, that Arnold Schwarzenegger.

He has a newsletter on beehiiv. So do Codie Sanchez, Jay Shetty, David Begnaud, Colin & Samir, and Joanna Stern.

They could publish just about anywhere. They chose beehiiv to build a direct connection with the people who want to hear from them most. And you can do the same, whether you’re world-famous or just at the start of your plan for world domination.

Get started for free.

CRITICAL CARE & DIGITAL TWINS
1. UVM Wins $38M ARPA-H Contract to Build Real-Time AI Digital Twins for ICU Sepsis and Trauma

The University of Vermont Larner College of Medicine has secured an R&D contract worth up to $38 million from ARPA-H under the CIRCLE program to develop ReSCUED, an AI-powered physiological digital twin designed to personalize immunotherapy and resuscitation for critically ill ICU patients in real time.

The details:

• Led by trauma surgeon Dr. Gary An, the ReSCUED project models disordered systemic immune responses driving sepsis, burns, and severe trauma, drawing patient blood every six hours to update a predictive computational digital twin.

• An AI 'virtual consultant' layer simulates the physiological impact of FDA-approved therapeutics in silico before clinicians administer them at the bedside, ranking intervention strategies for individual patient biology.

• Key technology partners include the DNA Medicine Institute (supplying space-station-grade bedside molecular testing) and InflammaSense (providing vagus nerve wearables to track systemic inflammatory tone).

• Clinical trials and multi-center validation will span Wake Forest University, the University of Alabama at Birmingham, and Washington University in St. Louis.

• The project targets a minimum 25% reduction in ICU length of stay, addressing an acute care burden that affects 4.6 million Americans annually at an estimated cost of $70 billion

The Signal: Intensive care medicine has struggled for decades with static protocols that fail to capture chaotic, rapidly evolving patient immune responses. By pairing bedside molecular sensors with dynamic in silico simulation, ReSCUED creates the first continuous computational testbed for personalized critical care, moving digital twins from chronic disease modeling directly into life-support units.

POINT-OF-CARE DIAGNOSTICS & HARDWARE AI
2. Eko Health Clears FDA 510(k) for CORE 300 AI Stethoscope to Scale Pediatric and Adult Cardiac Triage

Eko Health has announced FDA 510(k) clearance (K261694) and commercial launch for CORE 300, its next-generation AI stethoscope combining digital sound amplification, phonocardiogram visualization, and FDA-cleared structural heart algorithms at traditional acoustic price parity.

The details:

• · The CORE 300 integrates Eko's FDA-cleared AI algorithms to automatically detect heart murmurs, structural heart disease, and pulmonary abnormalities during routine physical exams in both pediatric and adult patients.

• Priced competitively with traditional premium analog acoustic stethoscopes, the device aims to eliminate the hardware price premium that has previously limited AI stethoscope adoption to specialized cardiology suites.

• The hardware streams acoustic phonocardiograms and wireless ECG telemetry directly into primary care EHR flowsheets, enabling immediate telemedicine sharing and longitudinal sound tracking.

• Clinical studies show that AI auscultation identifies valvular heart disease and structural defects with greater than 85% sensitivity, substantially outperforming standard primary care stethoscope auscultation.

• The commercial launch expands Eko's enterprise health system footprint as hospital networks standardize outpatient primary care physical exams on AI-connected diagnostic tools.

The Signal: Auscultation is the oldest diagnostic physical exam technique, yet acoustic stethoscopes have seen minimal structural evolution in two centuries. By integrating digital signal processing and cleared clinical AI into a device priced for universal clinician adoption, Eko Health is turning the standard physical exam into an automated frontline screening tool for cardiovascular disease.

RADIOLOGY & MUSCULOSKELETAL AI
3. RIVANNA Secures FDA Clearance for BoneEnhance 3D Machine Learning Module on Accuro XV Ultrasound

Charlottesville-based medical technology developer RIVANNA has received FDA 510(k) clearance for BoneEnhance, the first machine learning software module cleared for its Accuro XV volumetric diagnostic ultrasound system, automating skeletal anatomy segmentation in three dimensions.

The details:

• BoneEnhance automatically segments bony surfaces, cartilage interfaces, and surrounding soft tissues in real time, converting raw volumetric ultrasound data into standardized 3D skeletal anatomical maps during point-of-care image review

• The platform bridges the gap between ultrasound image acquisition and automated clinical interpretation, designed to aid anesthesiologists, orthopedic surgeons, and emergency physicians in spinal and musculoskeletal procedures.

• The software runs natively on the portable Accuro XV ultrasound console, which achieved initial volumetric imaging clearance earlier this year for conventional and superficial musculoskeletal applications.

• By providing automated 3D bone visualization without ionizing radiation, the system offers an alternative to CT scans for bedside needle guidance and orthopedic trauma assessments.

• Commercial rollout will target hospital anesthesia departments, acute pain services, and orthopedic outpatient surgical centers across North America and Europe.

The Signal: Point-of-care ultrasound (POCUS) adoption has historically been limited by operator skill and acoustic artifact interpretation. By using machine learning to automatically segment and reconstruct complex 3D skeletal structures in real time, BoneEnhance transforms handheld ultrasound into an intuitive anatomical navigation platform for non-radiologist clinicians.

👀 WHAT WE'RE WATCHING NEXT

• ARPA-H ReSCUED Digital Twin Milestones: Computational validation benchmarks over the next 12 months as UVM integrates continuous bedside molecular sensor telemetry from the DNA Medicine Institute.

• Primary Care Conversion Rates for Eko CORE 300: How rapidly large medical groups and health systems transition entire primary care clinician cohorts from traditional acoustic stethoscopes to AI-connected digital devices.

• Hospital Anesthesiology Adoption of 3D Ultrasound AI: Whether spinal anesthesia placement failure rates and procedural times decrease measurably as RIVANNA's BoneEnhance deploys across academic surgical suites.

💰 FOLLOW THE MONEY

The deals:

• University of Vermont (ReSCUED): $38M milestone-based ARPA-H contract to build real-time physiological digital twins for ICU care.

• Eko Health: Commercial launch of FDA-cleared CORE 300 AI stethoscope targeting mass-market primary care adoption.

• RIVANNA: Secured FDA 510(k) clearance for BoneEnhance 3D machine learning module on Accuro XV ultrasound.

The pattern: Capital allocation in late October 2026 is prioritizing point-of-care diagnostic leverage and high-acuity computational simulation. Venture and federal grant funding is heavily rewarding technologies that democratize specialist-level diagnostic interpretation at the bedside, whether by upgrading basic stethoscopes with cardiovascular AI (Eko), converting portable ultrasound into 3D skeletal navigation (RIVANNA), or simulating ICU drug responses via digital twins (UVM / ARPA-H).

📆 UPCOMING HEALTHTECH EVENTS

• HLTH 2026 Global Convening (November 15-18, 2026 | Las Vegas, Nevada): The premier industry gathering for digital health leaders, payers, and health systems shaping commercial AI agendas for 2027.

• ARPA-H SURPASS National Proposers Day (November 6, 2026 | Austin, TX & Virtual): Federal technical briefing for biopharma sponsors and AI developers bidding on adaptive clinical trial overhaul programs.

• RSNA 2026 (Radiological Society of North America) (November 29 - December 3, 2026 | McCormick Place, Chicago, IL): The global epicenter for clinical imaging AI, POCUS innovation, and volumetric ultrasound commercialization.

🛠️ Trending HealthTech AI Tools

• Eko CORE 300: FDA-cleared next-generation AI stethoscope combining digital amplification, phonocardiogram visualization, and automated structural heart triage at analog price parity.

• RIVANNA BoneEnhance: FDA-cleared 3D machine learning module for Accuro XV ultrasound that automatically segments bone and musculoskeletal anatomy in real time.

• 5 Digital Twin OS: ARPA-H-funded computational ICU digital twin platform simulating patient-specific immune response trajectories and ranking pharmacologic therapies.

🛠️ Trending HealthTech AI Startups

• Eko Health: Point-of-care cardiovascular and pulmonary AI company securing FDA 510(k) clearance for its CORE 300 connected stethoscope.

• RIVANNA: Charlottesville medtech developer expanding its Accuro XV ultrasound platform with FDA-cleared 3D machine learning bone segmentation.

• InflammaSense: Wearable medical technology company partnering on the $38M ARPA-H ReSCUED program to track vagus nerve inflammatory telemetry.

DECISION INTELLIGENCE

Highlights: Deep Dives & Industry Reports

• Physiological Digital Twins in the ICU: The ReSCUED $38M Blueprint: An in-depth analysis of UVM's $38M ARPA-H project modeling sepsis and trauma trajectories, evaluating six-hour molecular biomarker cycles, in silico drug response simulation, and the clinical economics of cutting ICU length of stay by 25%.

• AI at the Stethoscope: Eko CORE 300 and Point-of-Care Auscultation Economics: Examining how pricing AI-enabled diagnostic hardware at acoustic parity eliminates hospital procurement barriers, comparing

  detection sensitivity across primary care auscultation, and evaluating downstream cardiovascular referral triage.

• 3D Volumetric Ultrasound: RIVANNA BoneEnhance and Point-of-Care Skeletal AI: An operational guide to automated machine learning bone segmentation on portable ultrasound, analyzing radiation-free bedside imaging for anesthesiology and orthopedic trauma, and hospital ROI across outpatient surgical centers.

That's it for today!

The common realization connecting today's critical care simulations, acoustic AI stethoscopes, and volumetric ultrasound platforms is that point-of-care diagnostic leverage is the fastest path to clinical productivity. When specialist-grade diagnostic interpretation is delivered directly through standard bedside physical exam tools, health systems eliminate referral bottlenecks and identify life-threatening conditions before complications escalate.

As intelligent hardware reaches price parity with legacy instruments and digital twins move into acute hospital units, how is your organization architecting its clinical workflows for bedside AI enablement?

See you tomorrow,

Dr. Dereck Mush, MD, MBA

The HealthTech Signal is independently funded. Sponsorships help us invest in better reporting, research, and a stronger newsletter for our readers. Want to reach HealthTech founders & executives while supporting the Signal? Get in touch.

Was this email forwarded to you? Sign up here.